Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
94.14
-0.62 (-0.65%)
At close: Dec 2, 2025, 4:00 PM EST
95.56
+1.42 (1.51%)
After-hours: Dec 2, 2025, 7:33 PM EST
Zimmer Biomet Holdings Employees
Zimmer Biomet Holdings had 17,000 employees as of December 31, 2024. The number of employees decreased by 1,000 or -5.56% compared to the previous year.
Employees
17,000
Change (1Y)
-1,000
Growth (1Y)
-5.56%
Revenue / Employee
$471,229
Profits / Employee
$47,371
Market Cap
18.66B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17,000 | -1,000 | -5.56% |
| Dec 31, 2023 | 18,000 | 0 | - |
| Dec 31, 2022 | 18,000 | -1,500 | -7.69% |
| Dec 31, 2021 | 19,500 | -500 | -2.50% |
| Dec 31, 2020 | 20,000 | 100 | 0.50% |
| Dec 31, 2019 | 19,900 | 900 | 4.74% |
| Dec 31, 2018 | 19,000 | 800 | 4.40% |
| Dec 31, 2017 | 18,200 | -300 | -1.62% |
| Dec 31, 2016 | 18,500 | 1,000 | 5.71% |
| Dec 31, 2015 | 17,500 | 7,500 | 75.00% |
| Dec 31, 2014 | 10,000 | 500 | 5.26% |
| Dec 31, 2013 | 9,500 | 200 | 2.15% |
| Dec 31, 2012 | 9,300 | 600 | 6.90% |
| Dec 31, 2011 | 8,700 | -100 | -1.14% |
| Dec 31, 2010 | 8,800 | 600 | 7.32% |
| Dec 31, 2009 | 8,200 | -300 | -3.53% |
| Dec 31, 2008 | 8,500 | 900 | 11.84% |
| Dec 31, 2007 | 7,600 | 700 | 10.14% |
| Dec 31, 2006 | 6,900 | 200 | 2.99% |
| Dec 31, 2005 | 6,700 | 100 | 1.52% |
| Dec 31, 2004 | 6,600 | 100 | 1.54% |
| Dec 31, 2003 | 6,500 | 2,900 | 80.56% |
| Dec 31, 2002 | 3,600 | 200 | 5.88% |
| Dec 31, 2001 | 3,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZBH News
- 8 days ago - Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - GlobeNewsWire
- 12 days ago - Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm - GlobeNewsWire
- 14 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 15 days ago - Could Zimmer Biomet Stock Be Your Next Buy? - Forbes
- 18 days ago - Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology - PRNewsWire
- 25 days ago - Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London - PRNewsWire
- 26 days ago - Time To Buy Zimmer Biomet Stock? - Forbes
- 27 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call Transcript - Seeking Alpha